• Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.

Contact Us

If you are interested in joining the ADNI study as a participant, please visit adni3.org or call 1-888-223-6495 for more information.


If you have a question for ADNI, please browse our lists of frequently asked questions.

Contact Information

If you are interested in corresponding about a specific data type, please choose the appropriate email link. See the Data News and Recalls page for the latest news and information about ADNI data, including recalls, or to subscribe to a news feed.

For other inquiries, please review the Ask the Experts Knowledgeable and if you cannot find an answer, post a question on the Ask the Experts page

Admin Contact: Administrative Team

Clinical Contact: Alzheimer’s Therapeutic Research Institute: ADNI Team

Genetics Contact:  Indiana University School of Medicine

Informatics Contact: Laboratory of Neuro Imaging, USC

Biostatistics Contact: UC Davis

Biomarker Contact: University of Pennsylvania

MRI Contact: Mayo Clinic

Neuropathology Contact: Washington University

PET Contact: UC Berkeley

FNIH Contact: FNIH

Related Links

ADNI is associated with several organizations. See the related groups below:

The Alzheimer’s Disease Cooperative Study (ADCS) is a major initiative for Alzheimer’s disease clinical studies in the federal government, addressing treatments for both cognitive and behavioral symptoms. ADCS is part of the NIA Division of Neuroscience’s effort to facilitate the discovery, development and testing of new drugs for Alzheimer’s disease.
The Australian Imaging, Biomarkers & Lifestyle Flagship Study of Ageing (AIBL) is a study of over 1,100 people assessed to determine which biomarkers, cognitive characteristics, and health and lifestyle factors determine subsequent development of symptomatic Alzheimer’s disease.
The Alzheimer Research Forum reports on the latest scientific findings, from basic research to clinical trials and creates and maintains public databases of essential research data and reagents. The forum promotes debate and speeds the dissemination of new ideas while breaking down barriers across the numerous disciplines that can contribute to the global effort to cure Alzheimer’s disease.
Alzheimer’s Association
The Alzheimer’s Association is the leading, global voluntary health organization in Alzheimer’s care and support, and the largest private, nonprofit funder of Alzheimer’s research.
E-ADNI (European ADNI)
The aim of this pilot project is to demonstrate that the core ADNI methodology, i.e. standardized and centralized collection of MR imaging, clinical data, blood, and CSF samples can be adopted by European Centers of the European Alzheimer’s Disease Consortium (EADC).
J-ADNI (Japanese ADNI)
Japanese clinicians and researchers started Japanese ADNI (J-ADNI), which is sponsored by governmental funding bodies (NEDO and MHLW) as well as pharmas, in April 2007.